Company

AVIPERO Bio

Biotechnology Research Wilmington, Delaware, United States 4 employees

Employees: 4
Contacts: 1
Emails: 1

avipero.com LinkedIn

AVIPERO Bio Overview

Headquarters: Wilmington, Delaware, United States
Website: avipero.com
Industry: Biotechnology Research
Employees: 4
Founded: 2023
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in translational medicine and biotech innovation will be instrumental in shaping our scientific strategy.

About AVIPERO Bio

DEVELOPING UNIQUE Allosteric modulators of integrins for cancer: The dimmer switch analogy AVIPERO has unique Platform technology with multiple applications/indications. AVIPERO Bio is led by strong team with track record in drug development in cancer. At Avipero we aspire to revolutionize the treatment of malignant and degenerative diseases worldwide. We are dedicated to the study of advanced cancer, our pharmaceutical research company prioritizes the development of a non-destructive cure for this metastatic disease.

AVIPERO Bio Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

AVIPERO Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Mark Radford	Innovation, Business Leadership		View
Carlos Antonio Zambrano Vergara			View
Rehab Aljamal-Naylor	Chief Executive Officer at Avipero Bio	United States	Email